Sort   by:  
 Page size 
UnknownPointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Not available
S-EPMC4881367 | biostudies-literature
UnknownEGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
Not available
S-EPMC4922416 | biostudies-literature
UnknownImpact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics With the Medication Regimen Complexity-ICU (MRC-ICU) Score.
Not available
S-EPMC9612633 | biostudies-literature
Sort   by:  
 Page size